The next chapter of India's growth will not be written by more startups delivering existing products faster. It will be written by founders who create something the world has never seen before. India's startup story is genuinely remarkable. From under 500 recognised startups in 2016 to over 200,000 today, the country has built one of the largest entrepreneurial ecosystems on the planet in under a decade. Venture capital followed, and these startups raised over $160 billion since. Looking honestly at where capital has gone, and more importantly where it has not, the answer is clear: India has built a very prominent distribution ecosystem. Capital largely flowed to businesses that were brilliant at taking existing technology and delivering it to a billion people faster and cheaper. That is not nothing. But it is also not innovation on a global scale. Global innovation leadership requires the creation of fundamentally new technologies, scientific breakthroughs, and intellectual property that the rest of the world seeks to adopt. The numbers reflect both progress and the scale of the challenge ahead. In 2023, just 5% of Indian startup funding went into deeptech sectors. By 2025, that number had climbed to roughly 21%, a meaningful shift that reflects growing investor conviction in hard technology. But the work is far from done. In China, deeptech captured 38% of all VC funding in 2024, up from just 10% in 2017, a compounding, deliberate national bet, not a one-cycle trend. Meanwhile, India's R&D spending as a share of GDP sits at roughly 0.64%, against China's 2.68% and the United States' 3.47%. The private sector contributes just 36% of that already-thin number; in the US and China, private R&D contributions exceed 70%. These are not incidental gaps. They are structural ones. It reflects a decade of systematically underfunding the hardest problems. Consider where the world is headed. Climate technology, synthetic biology, and advanced materials are not just sectors, they are civilisational bets. No country has yet established a decisive, compounding lead in any of them. That is unusual. In semiconductors, the US and Taiwan have a multi-decade head start. In AI, concentration is already visible. But in the emerging biology-driven economy and in climate infrastructure, the field is still open. India's bioeconomy has grown from $10 billion in 2014 to over $165 billion in 2024, and this is expected to grow to $300 billion by 2030, a genuine signal of latent potential. We are the pharmacy of the world, the largest vaccine producer globally, and home to a growing network of research institutions. Synthetic biology, engineering biological systems to produce materials, medicines, and fuels, is a field where India's combination of scientific talent, cost advantage, and manufacturing base could translate into real global leadership. The government's BioE3 policy, launched in 2024, the creation of a National Biofoundry Network, and the consistent efforts put i
